Propanc Biopharma, Inc.: Form 8-K, filed Oct 2, 2017
Filed with the SEC on Oct 2, 2017 and accepted by EDGAR at Oct 2, 2017, 08:30 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.03 New direct financial obligation
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-17-011112. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.